🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

16 recruiting trials

for VWD - Von Willebrand's Disease

The Severe Von Willebrand Disease (sVWD) Patient Registry NCT05437536n/a1 site📍 Wellington VWD Connect Foundation A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) NCT05582993Phase 323 sites📍 Birmingham📍 Orlando📍 Peoria Takeda · Tests: Vonicog Alfa, ADVATE HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB NCT07575308Phase 221 sites📍 Orange📍 San Diego📍 San Francisco Alnylam Pharmaceuticals · Tests: ALN-6400 Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects NCT07358013n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Blood sample collection for VWF measurements in plasma, Blood sample collection for ECFC isolation and characterization… A Study Assessing HMB-002 in Participants With Von Willebrand Disease NCT06754852Phase 1, Phase 225 sites📍 Phoenix📍 Little Rock📍 Los Angeles Hemab ApS · Tests: HMB-002 (Part A), HMB-002 (Part B), HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US) A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD NCT06205095Phase 32 sites📍 Kingston📍 Toronto Unity Health Toronto · Tests: Lyophilized concentrate of human coagulation von Willebrand Factor and factor VIII, Placebo Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition NCT06090201n/a1 site📍 Lille University Hospital, Lille · Tests: 3-Tesla brain MRI and a comprehensive neuropsychological assessment Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease NCT06651255NA17 sites📍 Lille📍 Tours📍 Amiens University Hospital, Lille · Tests: Optimized management, Standard of care management Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) NCT07115004Phase 332 sites📍 Little Rock📍 Los Angeles📍 Palo Alto Vega Therapeutics, Inc · Tests: VGA039 A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD) NCT07129343Phase 37 sites📍 Beijing📍 Guangzhou📍 Jihan Takeda · Tests: VONVENDI, ADVATE Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) NCT05776069Phase 1, Phase 225 sites📍 Los Angeles📍 Sacramento📍 Aurora Vega Therapeutics, Inc · Tests: VGA039, Placebo, VGA039 A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease NCT07640893Phase 29 sites📍 Changsha📍 Hefei📍 Jinan Shanghai RAAS Blood Products Co., Ltd. · Tests: SR604 A Study of Bleeding and Treatment in Participants With Von Willebrand Disease NCT06610201n/a17 sites📍 Phoenix📍 Little Rock📍 Los Angeles Hemab ApS · Tests: Clinical outcomes of patients with VWD, Type 1, Clinical outcomes of patients with VWD, Type 2A, Type 2M, Type 2N, or T… Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A NCT05500807Phase 112 sites📍 Orange📍 Redwood City📍 Coral Gables Bleeding and Clotting Disorders Institute Peoria, Illinois · Tests: Emicizumab Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease NCT07273721Phase 21 site📍 Vienna Medical University of Vienna · Tests: BT200, Placebo An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD) NCT07404644n/a1 site📍 Tokyo Takeda · Tests: vonicog alfa (rVWF)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy